Answers go deeper than the script

HealthStream, Inc. (HSTM) — this company's answers

The model's full reasoning — Q3 2023 call → NOWe need to evaluate two gates based only on the transcript. Gate 1: Is there a positive, current development where Q&A produces more concrete operating detail than prepared remarks? Need to check if management's answers add new specifics. Gate 2: Is that development chiefly company-created and controlled, not external environment? Need to identify the main positive development probed. Let's analyze the transcript. Prepared remarks: Management highlights record revenue and adjusted EBITDA, growth in CredentialStream (56% revenue growth, 32 new customers), ShiftWizard (33% growth), expansion of share of wallet with existing customers (two examples with per-person revenue increases), expansion into nursing schools (myClinicalExchange growth, American Red Cross Resuscitation Suite sale to large nursing school), hStream subscriptions increase, etc. Q&A: Questions from analysts. Matt Hewitt asks about hospital market trends, then about nursing schools inclusion, then gross margins. Jared Haase asks about CredentialStream suite, then staffing. Richard Close asks about CredentialStream and ShiftWizard growth, then about revenue guidance, then product expenses, then myClinicalExchange revenue and who pays. Vincent Colicchio asks about revenue per employee, then identity management/license management, then acquisition contribution. Which positive development is probed with additional detail? CredentialStream: In prepared remarks, said 32 new customers, 114k new subscriptions, revenue growth 56%, named customers (Northwell, AlohaCare, Banner). In Q&A, when asked about CredentialStream, Bobby gives more detail about the suite's features, competitive position, Physician Hub, etc. But does that add concrete operating detail? He says "we have over 700 agreements on that core new application set" - that's new specific number. Also mentions about half from migration, half new. That's additional detail. Also discusses competitive wins. So yes, Q&A adds specifics like 700 agreements, migration split. myClinicalExchange: In prepared remarks, said year-to-date revenue $3M, up 27%, placed 161k rotations, and mentioned a large nursing school purchase. In Q&A, Richard Close asks about who pays. Bobby explains model: about 50% paid by students, 50% by hospitals, $30 per applicant, etc. That's new concrete detail about the business model and economics. That is substantive.

The model's full reasoning — Q3 2021 call → NOThe user wants me to evaluate the earnings call transcript against two gates and return only YES or NO. **Gate 1 — Original Signal:** I need to determine if there's a positive, current development in the company's business that management presents as genuinely going well, and whether the Q&A discussion produces MORE concrete operating detail than the prepared remarks contained. Let me look at the call. The prepared remarks cover: - Revenue growth of 5%, adjusted EBITDA up 15% - The three transitions being "put to bed" (Red Cross resuscitation, VerityStream credentialing, hStream platform) - Learning and development, credentialing and privileging, scheduling updates - NurseGrid growth, 47 new credentialing accounts, etc. In the Q&A, the questions were: 1. Jack Senft asked about the health of the client base and ED volumes returning. Bobby gave a general answer about regional impacts, workforce challenges, etc. This was more about the environment than a specific positive development with added detail. 2. Matt Hewitt asked about hybrid work model and recruiting nationally. Bobby discussed turnover, culture, hiring. This is about the company's operations but not really a "positive current development" being probed with added detail. 3. Richard Close asked about acquired/organic percentages (housekeeping), then about turnover characteristics. Bobby gave detail on turnover by department/experience level. 4. Vincent Colicchio asked about VerityStream migration and wage inflation. The key question: Is there a positive current development where the Q&A adds MORE concrete detail than the prepared remarks? Looking at the Q&A, the main topics probed were: - Client base health (general, environmental) - Turnover/hiring (this is actually a challenge, not a positive development) - VerityStream migration (Bobby gave the 31 new/16 migration split in response to a question, but this was in the closing remarks, not really a Q&A exchange) - Wage inflation The prepared remarks were quite detailed already. The Q&A mostly covered turnover (a problem), client health (environmental), and housekeeping. The VerityStream detail (31 new, 16 migrations) came in the closing remarks after the last question, not really as an additive Q&A exchange. Actually, looking more carefully, the Q&A doesn't seem to probe a specific positive development with additive detail.

The model's full reasoning — Q3 2017 call → NOWe need answer only YES or NO. Need evaluate both gates. We need parse transcript. Need identify positive current development that management highlights and analysts probe in Q&A, with more concrete operating detail than prepared remarks. Also engine is company's own actions. Let's examine. Prepared remarks: Q3 results strong. New products: Nurse Residency Pathway, OB Risk program co-developed with MedStar SiTEL. At end Q3, one of largest customers selected OB Risk program for system-wide deployment multiyear. Same account renewed enterprise-wide use core platform early, added 4 years, added Knowledge Q. Also new strategic partners for resuscitation after Laerdal agreement expires. Workforce segment growth driven by Knowledge Q. Patient Experience margin improvements. Provider Solutions organic growth. Q&A: Analysts ask about macro conditions, Laerdal, bad debt, new products addressable market, organic growth, content partners, ASC 606, Laerdal revenue, post-acute. Need see if any positive current development gets more concrete detail in Q&A than prepared remarks. Candidate: OB Risk program and large customer selection. In prepared remarks, already said one of largest customers selected OB Risk program for system-wide deployment multiyear, same account renewed early, added Knowledge Q. In Q&A, when asked about large OB Risk sale, Bobby says "It should be a fairly quick implementation. And there it has universal access to cost of system and it does not require hospital-to-hospital implementation. And so, it should be fairly linear once turned on, and now the contracts on pretty quickly, it should begin revenue recognition and product adoption utilization. So, I don’t see an issue that should be a pretty quick power of integration to turn that product on, and make probably available. And again these health systems are very familiar to using our platform, so the integration value is very higher than if they buy from us, they get the power of quick adoption..." This is somewhat additive? It describes implementation details, but not much new specifics about customer, volume, timing. It's more general. Also earlier in Q&A about new products addressable market, Bobby gives details on Knowledge Q and Nurse Residency pricing, but that's not necessarily the specific development? It is about new products generally.

← Back to the full HSTM analysis